Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jan;114(1):103–108. doi: 10.1111/j.1476-5381.1995.tb14912.x

Involvement of B2 receptors in the bradykinin-induced relaxation of guinea-pig isolated trachea.

A Da Silva 1, Y Amrani 1, A Trifilieff 1, Y Landry 1
PMCID: PMC1510188  PMID: 7712004

Abstract

1. The aim of this study was to determine the receptor type and involvement of arachidonic acid metabolites in bradykinin-induced relaxation of the guinea-pig isolated trachea. 2. In the resting tracheal preparation, bradykinin (0.1 nM-30 microM induced a concentration-related contractile response (pD2 = 8.8 +/- 0.3). The maximal tension (1056 +/- 321 mg) was observed at 0.3 microM bradykinin. In contrast, when tracheal preparations were pre-contracted with histamine (30 microM leading to a half-maximum response), a concentration-related relaxation was observed with bradykinin. At the highest concentration of bradykinin used (3 microM), a reversal of 63 +/- 13% of the contractile response to histamine was observed. Both effects of bradykinin were inhibited by the cyclo-oxygenase inhibitor, indomethacin (1 microM). In concentration-response curves, melittin (10 nM-1 microM), a direct activator of phospholipase A2, mimicked both effects of bradykinin. The highest concentration of melittin used (1 microM), induced a tension of 813 +/- 120 mg and led to the reversal of 41 +/- 8% of the contractile response to histamine. The contractile effect of melittin was inhibited in the presence of both indomethacin (1 microM) and AA861 (1 microM), a 5-lipoxygenase inhibitor. 3. [Des Arg9]-bradykinin (1 nM-3 microM), a B1-receptor agonist, was unable to relax precontracted guinea-pig tracheal preparations. The relaxation induced by bradykinin was antagonized by the B2 receptor antagonists, Hoe 140 (D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) and NPC 17761 (D-Arg0[Hyp3,D-HypE(trans-thiophenyl)7,Oic8]bradykinin ).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashida Y., Saijo T., Kuriki H., Makino H., Terao S., Maki Y. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostaglandins. 1983 Dec;26(6):955–972. doi: 10.1016/0090-6980(83)90157-0. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Bradykinin and asthma. Thorax. 1992 Nov;47(11):979–983. doi: 10.1136/thx.47.11.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bramley A. M., Samhoun M. N., Piper P. J. Effect of a bradykinin B2 antagonist on responses of intact and rubbed guinea-pig trachea in vitro. Br J Pharmacol. 1989 Dec;98 (Suppl):786P–786P. [PubMed] [Google Scholar]
  5. Bramley A. M., Samhoun M. N., Piper P. J. The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro. Br J Pharmacol. 1990 Apr;99(4):762–766. doi: 10.1111/j.1476-5381.1990.tb13003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braunstein G., Labat C., Brunelleschi S., Benveniste J., Marsac J., Brink C. Evidence that the histamine sensitivity and responsiveness of guinea-pig isolated trachea are modulated by epithelial prostaglandin E2 production. Br J Pharmacol. 1988 Sep;95(1):300–308. doi: 10.1111/j.1476-5381.1988.tb16577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Da Silva A., Dhuy J., Waeldelé F., Bertrand C., Landry Y. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea. Eur J Pharmacol. 1992 Feb 25;212(1):97–99. doi: 10.1016/0014-2999(92)90078-i. [DOI] [PubMed] [Google Scholar]
  8. Dixon C. M., Barnes P. J. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol. 1989 Jun;27(6):831–836. doi: 10.1111/j.1365-2125.1989.tb03446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dusser D. J., Nadel J. A., Sekizawa K., Graf P. D., Borson D. B. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea. J Pharmacol Exp Ther. 1988 Feb;244(2):531–536. [PubMed] [Google Scholar]
  10. Farmer S. G., Burch R. M., Kyle D. J., Martin J. A., Meeker S. N., Togo J. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors. Br J Pharmacol. 1991 Apr;102(4):785–787. doi: 10.1111/j.1476-5381.1991.tb12251.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Farmer S. G., Burch R. M., Meeker S. A., Wilkins D. E. Evidence for a pulmonary B3 bradykinin receptor. Mol Pharmacol. 1989 Jul;36(1):1–8. [PubMed] [Google Scholar]
  12. Farmer S. G., DeSiato M. A. Effects of a novel nonpeptide bradykinin B2 receptor antagonist on intestinal and airway smooth muscle: further evidence for the tracheal B3 receptor. Br J Pharmacol. 1994 Jun;112(2):461–464. doi: 10.1111/j.1476-5381.1994.tb13095.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Farmer S. G., Ensor J. E., Burch R. M. Evidence that cultured airway smooth muscle cells contain bradykinin B2 and B3 receptors. Am J Respir Cell Mol Biol. 1991 Mar;4(3):273–277. doi: 10.1165/ajrcmb/4.3.273. [DOI] [PubMed] [Google Scholar]
  14. Field J. L., Hall J. M., Morton I. K. Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea, and are blocked by HOE 140. Br J Pharmacol. 1992 Feb;105(2):293–296. doi: 10.1111/j.1476-5381.1992.tb14248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Frossard N., Stretton C. D., Barnes P. J. Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes. Agents Actions. 1990 Nov;31(3-4):204–209. doi: 10.1007/BF01997609. [DOI] [PubMed] [Google Scholar]
  16. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  17. Hall J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131–190. doi: 10.1016/0163-7258(92)90016-s. [DOI] [PubMed] [Google Scholar]
  18. Hock F. J., Wirth K., Albus U., Linz W., Gerhards H. J., Wiemer G., Henke S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol. 1991 Mar;102(3):769–773. doi: 10.1111/j.1476-5381.1991.tb12248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ichinose M., Nakajima N., Takahashi T., Yamauchi H., Inoue H., Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet. 1992 Nov 21;340(8830):1248–1251. doi: 10.1016/0140-6736(92)92948-f. [DOI] [PubMed] [Google Scholar]
  20. Johnson A. R., Ashton J., Schulz W. W., Erdös E. G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis. 1985 Sep;132(3):564–568. doi: 10.1164/arrd.1985.132.3.564. [DOI] [PubMed] [Google Scholar]
  21. Mizrahi J., D'Orléans-Juste P., Caranikas S., Regoli D. Effects of peptides and amines on isolated guinea pig tracheae as influenced by inhibitors of the metabolism of arachidonic acid. Pharmacology. 1982;25(6):320–326. doi: 10.1159/000137758. [DOI] [PubMed] [Google Scholar]
  22. Nijkamp F. P., Folkerts G. Reversal of arachidonic acid-induced guinea-pig tracheal relaxation into contraction after epithelium removal. Eur J Pharmacol. 1986 Nov 19;131(2-3):315–316. doi: 10.1016/0014-2999(86)90591-1. [DOI] [PubMed] [Google Scholar]
  23. Polosa R., Holgate S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1367–1371. doi: 10.1164/ajrccm/142.6_Pt_1.1367. [DOI] [PubMed] [Google Scholar]
  24. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
  25. Regoli D., Rhaleb N. E., Dion S., Drapeau G. New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends Pharmacol Sci. 1990 Apr;11(4):156–161. doi: 10.1016/0165-6147(90)90067-I. [DOI] [PubMed] [Google Scholar]
  26. Rhaleb N. E., Dion S., D'Orléans-Juste P., Drapeau G., Regoli D., Browne R. G. Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents. Eur J Pharmacol. 1988 Jul 7;151(2):275–279. doi: 10.1016/0014-2999(88)90808-4. [DOI] [PubMed] [Google Scholar]
  27. Rhaleb N. E., Rouissi N., Jukic D., Regoli D., Henke S., Breipohl G., Knolle J. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin). Eur J Pharmacol. 1992 Jan 14;210(2):115–120. doi: 10.1016/0014-2999(92)90661-m. [DOI] [PubMed] [Google Scholar]
  28. Schlemper V., Calixto J. B. Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea. Br J Pharmacol. 1994 Jan;111(1):83–88. doi: 10.1111/j.1476-5381.1994.tb14027.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shier W. T. Activation of high levels of endogenous phospholipase A2 in cultured cells. Proc Natl Acad Sci U S A. 1979 Jan;76(1):195–199. doi: 10.1073/pnas.76.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shikada K., Tanaka S. Influence of epithelium on the inhibition of melittin-induced contraction of guinea-pig isolated trachea by the potassium channel opener NIP-121. Br J Pharmacol. 1993 Aug;109(4):1091–1096. doi: 10.1111/j.1476-5381.1993.tb13734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stewart J. M., Vavrek R. J. Kinin antagonists: design and activities. J Cardiovasc Pharmacol. 1990;15 (Suppl 6):S69–S74. [PubMed] [Google Scholar]
  32. Trifilieff A., Amrani Y., Landry Y., Gies J. P. Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea. Eur J Pharmacol. 1993 Aug 3;239(1-3):227–229. doi: 10.1016/0014-2999(93)91000-d. [DOI] [PubMed] [Google Scholar]
  33. Trifilieff A., Da Silva A., Gies J. P. Kinins and respiratory tract diseases. Eur Respir J. 1993 Apr;6(4):576–587. [PubMed] [Google Scholar]
  34. Trifilieff A., Da Silva A., Landry Y., Gies J. P. Effect of Hoe 140, a new B2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors. J Pharmacol Exp Ther. 1992 Dec;263(3):1377–1382. [PubMed] [Google Scholar]
  35. Tschirhart E., Frossard N., Bertrand C., Landry Y. Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. J Pharmacol Exp Ther. 1987 Oct;243(1):310–316. [PubMed] [Google Scholar]
  36. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
  37. Vavrek R. J., Stewart J. M. Competitive antagonists of bradykinin. Peptides. 1985 Mar-Apr;6(2):161–164. doi: 10.1016/0196-9781(85)90033-6. [DOI] [PubMed] [Google Scholar]
  38. Wirth K., Hock F. J., Albus U., Linz W., Alpermann H. G., Anagnostopoulos H., Henk S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol. 1991 Mar;102(3):774–777. doi: 10.1111/j.1476-5381.1991.tb12249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yamamoto A., Shikada K., Tanaka S. Arachidonate lipoxygenase inhibitors in guinea-pig isolated trachea. Effects on contractions to antigen and various agonists. Prostaglandins. 1990 Dec;40(6):615–625. doi: 10.1016/0090-6980(90)90006-h. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES